Picture of JW Holdings logo

096760 JW Holdings Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareBalancedSmall CapContrarian

Momentum

Relative Strength (%)
1m+0.38%
3m+0.51%
6m+8.66%
1yr+1.65%
Volume Change (%)
10d/3m-44.89%
Price vs... (%)
52w High-22.41%
50d MA+0.14%
200d MA-1.53%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value0.93
Price to Tang. Book73.61
Price to Free Cashflow3.44
Price to Sales0.24
EV to EBITDA4.13

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital22.41%
Return on Equity35.43%
Operating Margin19.83%

Financial Summary

Year End 31st DecUnit202020212022202320242025E2026ECAGR / Avg
Total RevenueKR₩m781,514.84788,936.98864,536.43928,071.67887,710.03n/an/a4.09%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/a+58.16-1.47n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of JW Holdings EPS forecast chart

Profile Summary

JW Holdings Corp is a Korea-based company principally engaged in the production and sale of pharmaceuticals. The Company is principally engaged in the production and sale of pharmaceuticals such as antibiotics, antifungal agents, blood and body fluids substitutes, hyperlipidemia drugs, electrolyte additives, angina pills and digestive medicines. The Company is also engaged in the manufacture and sale of diagnostic equipment for hematology, immunology and others. In addition, the Company is engaged in the holding businesses.

Directors

Last Annual
December 31st, 2024
Last Interim
December 31st, 2024
Incorporated
July 3rd, 2007
Public Since
July 31st, 2007
No. of Shareholders
14,441
No. of Employees
161
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
kr flag iconKorea Exchange - KSE
Shares in Issue
70,678,703

096760 Share Price Performance

Upcoming Events for 096760

Q1 2025 JW Holdings Corp Earnings Release

Q2 2025 JW Holdings Corp Earnings Release

Similar to 096760

Picture of Aprogen Biologics logo

Aprogen Biologics

kr flag iconKorea Exchange - KSE

Picture of Boryung logo

Boryung

kr flag iconKorea Exchange - KSE

Picture of Bukwang Pharm Co logo

Bukwang Pharm Co

kr flag iconKorea Exchange - KSE

Picture of Chong Kun Dang Pharmaceutical logo

Chong Kun Dang Pharmaceutical

kr flag iconKorea Exchange - KSE

Picture of CKD Bio logo

CKD Bio

kr flag iconKorea Exchange - KSE

FAQ